Compounds > 4'-(9-acridinylamino)methanesulfon-o-anisidide
Page last updated: 2024-08-26

4'-(9-acridinylamino)methanesulfon-o-anisidide and Leukemia L 1210

4'-(9-acridinylamino)methanesulfon-o-anisidide has been researched along with Leukemia L 1210 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denny, WA; Ferguson, LR1
Erickson, LC; Kohn, KW; Michaels, S; Nichols, M; Ungerleider, RS; Zwelling, LA1
Barret, JM; Calsou, P; Larsen, AK; Salles, B1
Covey, JM; Kerrigan, D; Kohn, KW; Pommier, Y; Tilchen, EJ1
Beerman, TA; Sigmund, RD; Woynarowski, JM1

Other Studies

5 other study(ies) available for 4'-(9-acridinylamino)methanesulfon-o-anisidide and Leukemia L 1210

ArticleYear
Potential antitumor agents. 33. Quantitative structure--activity relationships for mutagenic activity and antitumor activity of substituted 4'-(9-acridinylamino)methanesulfonanilide derivatives.
    Journal of medicinal chemistry, 1980, Volume: 23, Issue:3

    Topics: Aminoacridines; Animals; Antineoplastic Agents; Leukemia L1210; Mathematics; Mice; Mutagens; Salmonella typhimurium; Solubility; Structure-Activity Relationship

1980
Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
    Biochemistry, 1981, Nov-10, Volume: 20, Issue:23

    Topics: Aminoacridines; Amsacrine; Animals; Biological Transport; Cell Survival; Deoxyribonucleoproteins; DNA, Single-Stranded; Doxorubicin; Intercalating Agents; Kinetics; Leukemia L1210; Mice; Nucleoproteins

1981
A cisplatin-resistant murine leukemia cell line exhibits increased topoisomerase II activity.
    Molecular pharmacology, 1994, Volume: 46, Issue:3

    Topics: Amino Acid Sequence; Amsacrine; Animals; Blotting, Western; Cell Survival; Cisplatin; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Kinetoplast; DNA, Neoplasm; DNA, Superhelical; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance; Enzyme Activation; Glutathione; Intercalating Agents; Leukemia L1210; Mice; Molecular Sequence Data; Tumor Cells, Cultured

1994
Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
    Cancer research, 1988, Feb-15, Volume: 48, Issue:4

    Topics: Aminoacridines; Amsacrine; Animals; Cell Nucleus; Cell Survival; DNA Damage; DNA Topoisomerases, Type II; Isomerism; Kinetics; Leukemia L1210; Mice; Structure-Activity Relationship

1988
Topoisomerase-II-mediated lesions in nascent DNA: comparison of the effects of epipodophyllotoxin derivatives, VM-26 and VP-16, and 9-anilinoacridine derivatives, m-AMSA and o-AMSA.
    Biochimica et biophysica acta, 1988, May-06, Volume: 950, Issue:1

    Topics: Adenosine Triphosphate; Amsacrine; Animals; Cross-Linking Reagents; DNA; DNA Damage; DNA Replication; DNA Topoisomerases, Type II; DNA, Neoplasm; Etoposide; Leukemia L1210; Mice; Novobiocin; Podophyllotoxin; Teniposide; Topoisomerase II Inhibitors

1988